Annual CAPEX
$3.15 M
-$1.08 M-25.54%
31 December 2023
Summary:
TScan Therapeutics annual capital expenditures is currently $3.15 million, with the most recent change of -$1.08 million (-25.54%) on 31 December 2023. During the last 3 years, it has fallen by -$1.09 million (-25.77%). TCRX annual CAPEX is now -68.35% below its all-time high of $9.94 million, reached on 31 December 2021.TCRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$1.37 M
+$508.00 K+58.93%
30 September 2024
Summary:
TScan Therapeutics quarterly capital expenditures is currently $1.37 million, with the most recent change of +$508.00 thousand (+58.93%) on 30 September 2024. Over the past year, it has dropped by -$49.00 thousand (-3.45%). TCRX quarterly CAPEX is now -65.03% below its all-time high of $3.92 million, reached on 30 June 2021.TCRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$3.41 M
-$49.00 K-1.42%
30 September 2024
Summary:
TScan Therapeutics TTM capital expenditures is currently $3.41 million, with the most recent change of -$49.00 thousand (-1.42%) on 30 September 2024. Over the past year, it has dropped by -$648.00 thousand (-15.98%). TCRX TTM CAPEX is now -65.74% below its all-time high of $9.94 million, reached on 31 December 2021.TCRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.5% | -3.5% | -16.0% |
| 3 y3 years | -25.8% | +60.6% | -62.6% |
| 5 y5 years | - | - | - |
TCRX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -68.3% | at low | -38.0% | +226.2% | -65.7% | +13.0% |
| 5 y | 5 years | -68.3% | at low | -65.0% | +226.2% | -65.7% | +153.6% |
| alltime | all time | -68.3% | at low | -65.0% | +226.2% | -65.7% | +153.6% |
TScan Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.37 M(+58.9%) | $3.41 M(-1.4%) |
| June 2024 | - | $862.00 K(+22.3%) | $3.46 M(+14.7%) |
| Mar 2024 | - | $705.00 K(+50.3%) | $3.01 M(-4.2%) |
| Dec 2023 | $3.15 M(-25.5%) | $469.00 K(-66.9%) | $3.15 M(-22.4%) |
| Sept 2023 | - | $1.42 M(+237.9%) | $4.05 M(+32.5%) |
| June 2023 | - | $420.00 K(-49.9%) | $3.06 M(-32.5%) |
| Mar 2023 | - | $838.00 K(-39.1%) | $4.53 M(+7.3%) |
| Dec 2022 | $4.22 M | $1.38 M(+224.8%) | $4.22 M(-16.5%) |
| Sept 2022 | - | $424.00 K(-77.6%) | $5.06 M(-7.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $1.89 M(+256.5%) | $5.49 M(-27.0%) |
| Mar 2022 | - | $531.00 K(-76.0%) | $7.51 M(-24.4%) |
| Dec 2021 | $9.94 M(+134.6%) | $2.21 M(+159.2%) | $9.94 M(+9.1%) |
| Sept 2021 | - | $853.00 K(-78.2%) | $9.12 M(-5.1%) |
| June 2021 | - | $3.92 M(+32.4%) | $9.61 M(+68.9%) |
| Mar 2021 | - | $2.96 M(+113.6%) | $5.69 M(+108.5%) |
| Dec 2020 | $4.24 M | - | - |
| Dec 2020 | - | $1.39 M(+3.1%) | $2.73 M(+103.1%) |
| Sept 2020 | - | $1.34 M | $1.34 M |
FAQ
- What is TScan Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for TScan Therapeutics?
- What is TScan Therapeutics annual CAPEX year-on-year change?
- What is TScan Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for TScan Therapeutics?
- What is TScan Therapeutics quarterly CAPEX year-on-year change?
- What is TScan Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for TScan Therapeutics?
- What is TScan Therapeutics TTM CAPEX year-on-year change?
What is TScan Therapeutics annual capital expenditures?
The current annual CAPEX of TCRX is $3.15 M
What is the all time high annual CAPEX for TScan Therapeutics?
TScan Therapeutics all-time high annual capital expenditures is $9.94 M
What is TScan Therapeutics annual CAPEX year-on-year change?
Over the past year, TCRX annual capital expenditures has changed by -$1.08 M (-25.54%)
What is TScan Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of TCRX is $1.37 M
What is the all time high quarterly CAPEX for TScan Therapeutics?
TScan Therapeutics all-time high quarterly capital expenditures is $3.92 M
What is TScan Therapeutics quarterly CAPEX year-on-year change?
Over the past year, TCRX quarterly capital expenditures has changed by -$49.00 K (-3.45%)
What is TScan Therapeutics TTM capital expenditures?
The current TTM CAPEX of TCRX is $3.41 M
What is the all time high TTM CAPEX for TScan Therapeutics?
TScan Therapeutics all-time high TTM capital expenditures is $9.94 M
What is TScan Therapeutics TTM CAPEX year-on-year change?
Over the past year, TCRX TTM capital expenditures has changed by -$648.00 K (-15.98%)